Transjugular intrahepatic Porto-systemic shunt positively influences the composition and metabolic functions of the gut microbiota in cirrhotic patients.

[1]  A. Amedei,et al.  Crohn’s disease recurrence updates: first surgery vs. surgical relapse patients display different profiles of ileal microbiota and systemic microbial-associated inflammatory factors , 2022, Frontiers in Immunology.

[2]  Christian H. Holland,et al.  Imbalanced gut microbiota fuels hepatocellular carcinoma development by shaping the hepatic inflammatory microenvironment , 2022, Nature Communications.

[3]  J. Trebicka,et al.  Restoration of the gut microbiota is associated with a decreased risk of hepatic encephalopathy after TIPS , 2022, JHEP reports : innovation in hepatology.

[4]  T. Madl,et al.  Oral Intake of L-Ornithine-L-Aspartate Is Associated with Distinct Microbiome and Metabolome Changes in Cirrhosis , 2022, Nutrients.

[5]  C. Fraser,et al.  Gut microbiome and metabolome in a non-human primate model of chronic excessive alcohol drinking , 2021, Translational Psychiatry.

[6]  S. Shetty,et al.  Effect of medium chain fatty acid in human health and disease , 2021, Journal of Functional Foods.

[7]  M. Chang,et al.  The Divergent Immunomodulatory Effects of Short Chain Fatty Acids and Medium Chain Fatty Acids , 2021, International journal of molecular sciences.

[8]  P. Kralickova,et al.  Gut Microbiota and NAFLD: Pathogenetic Mechanisms, Microbiota Signatures, and Therapeutic Interventions , 2021, Microorganisms.

[9]  F. Milagro,et al.  Gut Microbiota Bacterial Species Associated with Mediterranean Diet-Related Food Groups in a Northern Spanish Population , 2021, Nutrients.

[10]  P. Kanmani,et al.  The Gut Microbiota: How Does It Influence the Development and Progression of Liver Diseases , 2020, Biomedicines.

[11]  K. Schuebel,et al.  Longitudinal gut microbiome changes in alcohol use disorder are influenced by abstinence and drinking quantity , 2020, Gut microbes.

[12]  R. Fani,et al.  Significant and Conflicting Correlation of IL-9 With Prevotella and Bacteroides in Human Colorectal Cancer , 2020, bioRxiv.

[13]  T. Luedde,et al.  The Medium-Chain Fatty Acid Receptor GPR84 Mediates Myeloid Cell Infiltration Promoting Steatohepatitis and Fibrosis , 2020, Journal of clinical medicine.

[14]  F. Marra,et al.  Transjugular intrahepatic portosystemic shunt (TIPS): current indications and strategies to improve the outcomes , 2020, Internal and Emergency Medicine.

[15]  H. Fukui.  Role of Gut Dysbiosis in Liver Diseases: What Have We Learned So Far? , 2019, Diseases.

[16]  J. Grove,et al.  Lower gut microbiome diversity and higher abundance of proinflammatory genus Collinsella are associated with biopsy-proven nonalcoholic steatohepatitis , 2019, Gut microbes.

[17]  F. Stingo,et al.  Evaluation and comparison of short chain fatty acids composition in gut diseases , 2019, World journal of gastroenterology.

[18]  Xing-Ming Zhao,et al.  GMrepo: a database of curated and consistently annotated human gut metagenomes , 2019, Nucleic Acids Res..

[19]  S. Walk,et al.  Rethinking gut microbiome residency and the Enterobacteriaceae in healthy human adults , 2019, The ISME Journal.

[20]  Robert A. Gilmore,et al.  Alcohol-induced changes in the gut microbiome and metabolome of rhesus macaques , 2019, Psychopharmacology.

[21]  G. Baffy.  Potential mechanisms linking gut microbiota and portal hypertension , 2018, Liver international : official journal of the International Association for the Study of the Liver.

[22]  T. Dandekar,et al.  Fecal SCFAs and SCFA-producing bacteria in gut microbiome of human NAFLD as a putative link to systemic T-cell activation and advanced disease , 2018, United European gastroenterology journal.

[23]  R. Bruno,et al.  Under‐dilated TIPS Associate With Efficacy and Reduced Encephalopathy in a Prospective, Non‐randomized Study of Patients With Cirrhosis , 2018, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[24]  G. Wynne,et al.  Activation of the Immune-Metabolic Receptor GPR84 Enhances Inflammation and Phagocytosis in Macrophages , 2018, Front. Immunol..

[25]  Huinan Chen,et al.  Small Bowel Transit and Altered Gut Microbiota in Patients With Liver Cirrhosis , 2018, Front. Physiol..

[26]  V. Shah,et al.  Gut–liver axis, cirrhosis and portal hypertension: the chicken and the egg , 2018, Hepatology International.

[27]  Jian-Gao Fan,et al.  Gut microbiota dysbiosis in patients with non-alcoholic fatty liver disease. , 2017, Hepatobiliary & pancreatic diseases international : HBPD INT.

[28]  R. Bruno,et al.  Consensus conference on TIPS management: Techniques, indications, contraindications. , 2017, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[29]  Lanjuan Li,et al.  Dysbiosis of small intestinal microbiota in liver cirrhosis and its association with etiology , 2016, Scientific Reports.

[30]  F. Bäckhed,et al.  From Dietary Fiber to Host Physiology: Short-Chain Fatty Acids as Key Bacterial Metabolites , 2016, Cell.

[31]  C. Huttenhower,et al.  The healthy human microbiome , 2016, Genome Medicine.

[32]  Zongxin Ling,et al.  Decreased Diversity of the Oral Microbiota of Patients with Hepatitis B Virus-Induced Chronic Liver Disease: A Pilot Project , 2015, Scientific Reports.

[33]  R. Gold,et al.  Dietary Fatty Acids Directly Impact Central Nervous System Autoimmunity via the Small Intestine. , 2015, Immunity.

[34]  Jing Li,et al.  Dysbiosis gut microbiota associated with inflammation and impaired mucosal immune function in intestine of humans with non-alcoholic fatty liver disease , 2015, Scientific Reports.

[35]  W. Huber,et al.  Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2 , 2014, Genome Biology.

[36]  Sébastien Matamoros,et al.  Intestinal permeability, gut-bacterial dysbiosis, and behavioral markers of alcohol-dependence severity , 2014, Proceedings of the National Academy of Sciences.

[37]  J. Talwalkar,et al.  Hepatic encephalopathy in chronic liver disease: 2014 practice guideline by the European Association for the Study of the Liver and the American Association for the Study of Liver Diseases. , 2014, Journal of hepatology.

[38]  Susan Holmes,et al.  phyloseq: An R Package for Reproducible Interactive Analysis and Graphics of Microbiome Census Data , 2013, PloS one.

[39]  E. Chang,et al.  Short-chain fatty acids impact on intestinal adaptation, inflammation, carcinoma, and failure. , 2006, Gastroenterology.

[40]  J. Bajaj,et al.  Altered Microbiome in Patients With Cirrhosis and Complications , 2019, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[41]  H. Flint,et al.  Formation of propionate and butyrate by the human colonic microbiota. , 2017, Environmental microbiology.